Smith & Nephew SNATS Inc (SNN)
NYSE · Healthcare · Medical Devices
Smith & Nephew SNATS Inc is a Healthcare company with a market capitalization of $12.69B, a trailing P/E ratio of 21.0, and a dividend yield of 2.60%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.00 | $0.00 | — |
| Q4 2025 | March 2, 2026 | $0.38 | $1.12 | -66.1% |
| Q3 2025 | November 6, 2025 | $0.00 | $0.00 | — |
| Q2 2025 | August 5, 2025 | $0.33 | $1.03 | -68.0% |
| Q1 2025 | April 30, 2025 | $0.00 | $0.00 | — |
| Q4 2024 | February 25, 2025 | $0.23 | $0.97 | -76.3% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Smith & Nephew SNATS Inc's market cap?
As of June 29, 2026, Smith & Nephew SNATS Inc (SNN) has a market capitalization of $12.69B.
What is Smith & Nephew SNATS Inc's P/E ratio?
Smith & Nephew SNATS Inc trades at a trailing price-to-earnings (P/E) ratio of 21.0. Its forward P/E is 13.6.
Does Smith & Nephew SNATS Inc pay a dividend?
Yes — Smith & Nephew SNATS Inc pays a dividend yielding 2.60%, an annual payout of $0.39 per share.
What sector is SNN in?
Smith & Nephew SNATS Inc is in the Healthcare sector, specifically the Medical Devices industry.
What was Smith & Nephew SNATS Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Smith & Nephew SNATS Inc reported revenue of $6.18B and net income of $626.46M.
Ask your own questions about SNN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.